CELL INTELLIGENCE · 肿瘤细胞治疗研究

开发基于溶瘤病毒递送 CD19 和 EGFRvIII 抗原与双特异性 CAR 的胶质母细胞瘤多模式治疗

Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs.

通过编码双特异性 T 细胞衔接器的溶瘤腺病毒改造微环境以实现胶质母细胞瘤中的 CAR-T 细胞免疫治疗

Enable CAR T cell immunotherapy in glioblastoma by modifying its microenvironment via oncolytic adenovirus encoding bispecific T cell engager.

胶质母细胞瘤免疫治疗：当前策略与进展前景的系统综述

Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.

推进胶质母细胞瘤免疫治疗：分子通路与创新治疗策略

Advancing glioblastoma immunotherapy: Molecular pathways and innovative therapeutic strategies.

胶质母细胞瘤 CAR-T 细胞治疗的全球研究趋势：一项文献计量学和可视化分析

Global research trends in CAR-T cell therapy for glioblastoma: a bibliometric and visualized analysis.

本研究描绘了 CAR-T 细胞治疗在 GBM 中不断演变的科学图景，凸显了关键贡献者、机构合作以及新兴研究前沿。

通过编码双特异性 T 细胞衔接器的溶瘤腺病毒改造肿瘤微环境以实现胶质母细胞瘤 CAR-T 细胞免疫治疗

Enabling CAR-T Cell Immunotherapy in Glioblastoma by Modifying Tumor Microenvironment via Oncolytic Adenovirus Encoding Bispecific T Cell Engager.

免疫治疗作为脑与脊髓肿瘤的新治疗途径

Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.